Background: Heated tobacco products (HTPs) have emerged as alternatives to conventional cigarettes. However, their health effects remain largely unknown. This study aimed to prospectively explore the association between the use of cigarettes and HTPs and the risk of hypertension.
Methods: This cohort study analysed data from 30 152 workers (82.0% men, mean age 42.9 ± 11.0 years) who were initially free of hypertension, participating in the Japan Epidemiology Collaboration on Occupational Health Study. Participants were categorized into five groups based on their self-reported tobacco product use: never smokers, past smokers, exclusive cigarette smokers, exclusive HTP users and dual users of cigarettes and HTPs. Hypertension cases were identified using three data points from annual health checkup data collected between 2019 and 2021. Cox proportional hazards regression models were used to investigate the association between tobacco product use and hypertension.
Results: During a mean follow-up of 2.6 years (range: 0.1-4.0 years), 3656 new cases of hypertension were identified. Compared with never smokers, the risk of hypertension was higher among exclusive cigarette smokers [hazard ratio (HR) 1.26, 95% confidence interval (CI) 1.13-1.41] and exclusive HTP users (HR 1.19, 95% CI 1.06-1.34). There was also a suggestion of increased risk of hypertension among dual users (HR 1.16, 95% CI 0.98-1.38). Furthermore, the risk of hypertension increased with the intensity of cigarette/HTP use in all tobacco product users.
Conclusions: Similarly, both cigarette smoking and HTP use elevate the risk of hypertension. HTPs should not be regarded as less harmful alternatives to traditional cigarettes for preventing hypertension.
{"title":"Association of conventional cigarette smoking, heated tobacco product use and dual use with hypertension.","authors":"Huan Hu, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Tetsuya Mizoue","doi":"10.1093/ije/dyae114","DOIUrl":"10.1093/ije/dyae114","url":null,"abstract":"<p><strong>Background: </strong>Heated tobacco products (HTPs) have emerged as alternatives to conventional cigarettes. However, their health effects remain largely unknown. This study aimed to prospectively explore the association between the use of cigarettes and HTPs and the risk of hypertension.</p><p><strong>Methods: </strong>This cohort study analysed data from 30 152 workers (82.0% men, mean age 42.9 ± 11.0 years) who were initially free of hypertension, participating in the Japan Epidemiology Collaboration on Occupational Health Study. Participants were categorized into five groups based on their self-reported tobacco product use: never smokers, past smokers, exclusive cigarette smokers, exclusive HTP users and dual users of cigarettes and HTPs. Hypertension cases were identified using three data points from annual health checkup data collected between 2019 and 2021. Cox proportional hazards regression models were used to investigate the association between tobacco product use and hypertension.</p><p><strong>Results: </strong>During a mean follow-up of 2.6 years (range: 0.1-4.0 years), 3656 new cases of hypertension were identified. Compared with never smokers, the risk of hypertension was higher among exclusive cigarette smokers [hazard ratio (HR) 1.26, 95% confidence interval (CI) 1.13-1.41] and exclusive HTP users (HR 1.19, 95% CI 1.06-1.34). There was also a suggestion of increased risk of hypertension among dual users (HR 1.16, 95% CI 0.98-1.38). Furthermore, the risk of hypertension increased with the intensity of cigarette/HTP use in all tobacco product users.</p><p><strong>Conclusions: </strong>Similarly, both cigarette smoking and HTP use elevate the risk of hypertension. HTPs should not be regarded as less harmful alternatives to traditional cigarettes for preventing hypertension.</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11341126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Natalie V Scime, Sonia M Grandi, Joel G Ray, Cindy-Lee Dennis, Mary A De Vera, Hailey R Banack, Simone N Vigod, Alexa Boblitz, Hilary K Brown
Background: Autoimmune diseases disproportionately impact women and female-specific aspects of reproduction are thought to play a role. We investigated the time-varying association between pregnancy complications and new-onset autoimmune disease in females during the reproductive and midlife years.
Methods: We conducted a population-based cohort study of 1 704 553 singleton births to 1 072 445 females in Ontario, Canada (2002-17) with no pre-existing autoimmune disease. Pregnancy complications were preeclampsia, stillbirth, spontaneous preterm birth and severe small for gestational age (SGA). Royston-Parmar models were used to estimate the time-varying association between pregnancy complications and a composite of 25 autoimmune diseases from date of delivery to date of autoimmune disease diagnosis or censoring at death, loss of health insurance, or 31 March 2021. Models were adjusted for baseline socio-demographics, parity and comorbidities.
Results: At 19 years (median = 10.9 years of follow-up), cumulative incidence of autoimmune disease was 3.1% in those with a pregnancy complication and 2.6% in those without complications. Adjusted hazard ratio (AHR) curves as a function of time since birth were generally L-shaped. Universally, risks were most elevated within the first 3 years after birth [at 1 year: preeclampsia AHR 1.22, 95% confidence interval (CI) 1.09-1.36; stillbirth AHR 1.36, 95% CI 0.99-1.85; spontaneous preterm birth AHR 1.30, 95% CI 1.18-1.44; severe SGA AHR 1.14, 95% CI 0.99-1.31] and plateaued but remained elevated thereafter.
Conclusions: Prior history of pregnancy complications may be an important female-specific risk factor to consider during clinical assessment of females for possible autoimmune disease to facilitate timely detection and treatment.
背景:自身免疫性疾病对女性的影响尤为严重,而女性特有的生殖问题被认为是其中的一个因素。我们研究了女性在生育期和中年时期妊娠并发症与新发自身免疫性疾病之间的时变关系:我们对加拿大安大略省(2002-17 年)1 704 553 例单胎分娩和 1 072 445 例未患自身免疫性疾病的女性进行了基于人群的队列研究。妊娠并发症包括子痫前期、死胎、自发性早产和严重胎龄过小 (SGA)。罗伊斯顿-帕尔马模型用于估计妊娠并发症与 25 种自身免疫性疾病复合体之间的时变关系,时间跨度为分娩日期至自身免疫性疾病诊断日期或死亡、失去医疗保险或 2021 年 3 月 31 日。模型根据基线社会人口统计学、奇偶性和合并症进行了调整:19年(中位数=10.9年随访)后,妊娠并发症患者的自身免疫性疾病累积发病率为3.1%,无并发症患者的自身免疫性疾病累积发病率为2.6%。调整后危险比(AHR)曲线与出生后时间的关系一般呈 L 型。总体而言,产后头 3 年的风险最高[1 年时:子痫前期 AHR 1.22,95% 置信区间(CI)1.09-1.36;死胎 AHR 1.36,95% CI 0.99-1.85;自发性早产 AHR 1.30,95% CI 1.18-1.44;严重 SGA AHR 1.14,95% CI 0.99-1.31],之后风险趋于平稳,但仍然较高:在对可能患有自身免疫性疾病的女性进行临床评估时,既往妊娠并发症史可能是一个重要的女性特异性风险因素,以便及时发现和治疗。
{"title":"Pregnancy complications and new-onset maternal autoimmune disease.","authors":"Natalie V Scime, Sonia M Grandi, Joel G Ray, Cindy-Lee Dennis, Mary A De Vera, Hailey R Banack, Simone N Vigod, Alexa Boblitz, Hilary K Brown","doi":"10.1093/ije/dyae115","DOIUrl":"10.1093/ije/dyae115","url":null,"abstract":"<p><strong>Background: </strong>Autoimmune diseases disproportionately impact women and female-specific aspects of reproduction are thought to play a role. We investigated the time-varying association between pregnancy complications and new-onset autoimmune disease in females during the reproductive and midlife years.</p><p><strong>Methods: </strong>We conducted a population-based cohort study of 1 704 553 singleton births to 1 072 445 females in Ontario, Canada (2002-17) with no pre-existing autoimmune disease. Pregnancy complications were preeclampsia, stillbirth, spontaneous preterm birth and severe small for gestational age (SGA). Royston-Parmar models were used to estimate the time-varying association between pregnancy complications and a composite of 25 autoimmune diseases from date of delivery to date of autoimmune disease diagnosis or censoring at death, loss of health insurance, or 31 March 2021. Models were adjusted for baseline socio-demographics, parity and comorbidities.</p><p><strong>Results: </strong>At 19 years (median = 10.9 years of follow-up), cumulative incidence of autoimmune disease was 3.1% in those with a pregnancy complication and 2.6% in those without complications. Adjusted hazard ratio (AHR) curves as a function of time since birth were generally L-shaped. Universally, risks were most elevated within the first 3 years after birth [at 1 year: preeclampsia AHR 1.22, 95% confidence interval (CI) 1.09-1.36; stillbirth AHR 1.36, 95% CI 0.99-1.85; spontaneous preterm birth AHR 1.30, 95% CI 1.18-1.44; severe SGA AHR 1.14, 95% CI 0.99-1.31] and plateaued but remained elevated thereafter.</p><p><strong>Conclusions: </strong>Prior history of pregnancy complications may be an important female-specific risk factor to consider during clinical assessment of females for possible autoimmune disease to facilitate timely detection and treatment.</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11349189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142080273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charis Bridger Staatz, Iliya Gutin, Andrea Tilstra, Laura Gimeno, Bettina Moltrecht, Dario Moreno-Agostino, Vanessa Moulton, Martina K Narayanan, Jennifer B Dowd, Lauren Gaydosh, George B Ploubidis
Background: Older adults in the USA have worse health and wider socioeconomic inequalities in health compared with those in Britain. Less is known about how health in the two countries compares in mid-life, a time of emerging health decline, including inequalities in health.
Methods: We compare measures of current regular smoking status, obesity, self-rated health, cholesterol, blood pressure and glycated haemoglobin using population-weighted modified Poisson regression in the 1970 British Cohort Study (BCS70) in Britain (N = 9665) and the National Longitudinal Study of Adolescent to Adult Health (Add Health) in the USA (N = 12 300), when cohort members were aged 34-46 and 33-43, respectively. We test whether associations vary by early- and mid-life socioeconomic position.
Results: US adults had higher levels of obesity, high blood pressure and high cholesterol. Prevalence of poor self-rated health and current regular smoking was worse in Britain. We found smaller socioeconomic inequalities in mid-life health in Britain compared with the USA. For some outcomes (e.g. smoking), the most socioeconomically advantaged group in the USA was healthier than the equivalent group in Britain. For other outcomes (hypertension and cholesterol), the most advantaged US group fared equal to or worse than the most disadvantaged groups in Britain.
Conclusions: US adults have worse cardiometabolic health than British counterparts, even in early mid-life. The smaller socioeconomic inequalities and better overall health in Britain may reflect differences in access to health care, welfare systems or other environmental risk factors.
{"title":"Midlife health in Britain and the United States: a comparison of two nationally representative cohorts.","authors":"Charis Bridger Staatz, Iliya Gutin, Andrea Tilstra, Laura Gimeno, Bettina Moltrecht, Dario Moreno-Agostino, Vanessa Moulton, Martina K Narayanan, Jennifer B Dowd, Lauren Gaydosh, George B Ploubidis","doi":"10.1093/ije/dyae127","DOIUrl":"10.1093/ije/dyae127","url":null,"abstract":"<p><strong>Background: </strong>Older adults in the USA have worse health and wider socioeconomic inequalities in health compared with those in Britain. Less is known about how health in the two countries compares in mid-life, a time of emerging health decline, including inequalities in health.</p><p><strong>Methods: </strong>We compare measures of current regular smoking status, obesity, self-rated health, cholesterol, blood pressure and glycated haemoglobin using population-weighted modified Poisson regression in the 1970 British Cohort Study (BCS70) in Britain (N = 9665) and the National Longitudinal Study of Adolescent to Adult Health (Add Health) in the USA (N = 12 300), when cohort members were aged 34-46 and 33-43, respectively. We test whether associations vary by early- and mid-life socioeconomic position.</p><p><strong>Results: </strong>US adults had higher levels of obesity, high blood pressure and high cholesterol. Prevalence of poor self-rated health and current regular smoking was worse in Britain. We found smaller socioeconomic inequalities in mid-life health in Britain compared with the USA. For some outcomes (e.g. smoking), the most socioeconomically advantaged group in the USA was healthier than the equivalent group in Britain. For other outcomes (hypertension and cholesterol), the most advantaged US group fared equal to or worse than the most disadvantaged groups in Britain.</p><p><strong>Conclusions: </strong>US adults have worse cardiometabolic health than British counterparts, even in early mid-life. The smaller socioeconomic inequalities and better overall health in Britain may reflect differences in access to health care, welfare systems or other environmental risk factors.</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11446604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Elizabeth M Lawrence,Elyssa A Trani,Kurtis M Anthony,Robert A Hummer,Tiffany Jensen,Sylvie Tuder,Laura R Loehr,Kathleen Mullan Harris,Eric A Whitsel
{"title":"Data Resource Profile: Add Health Mortality Outcomes Surveillance.","authors":"Elizabeth M Lawrence,Elyssa A Trani,Kurtis M Anthony,Robert A Hummer,Tiffany Jensen,Sylvie Tuder,Laura R Loehr,Kathleen Mullan Harris,Eric A Whitsel","doi":"10.1093/ije/dyae121","DOIUrl":"https://doi.org/10.1093/ije/dyae121","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"1 1","pages":""},"PeriodicalIF":7.7,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142263997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Food, health, and climate change: can epidemiologists contribute further?","authors":"Walter Willett, Marco Springmann","doi":"10.1093/ije/dyae109","DOIUrl":"https://doi.org/10.1093/ije/dyae109","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ryan M Andrews, Christine W Bang, Vanessa Didelez, Janine Witte, Ronja Foraita
Motivation: The Peter Clark (PC) algorithm is a popular causal discovery method to learn causal graphs in a data-driven way. Until recently, existing PC algorithm implementations in R had important limitations regarding missing values, temporal structure or mixed measurement scales (categorical/continuous), which are all common features of cohort data. The new R packages presented here, micd and tpc, fill these gaps.
Implementation: micd and tpc packages are R packages.
General features: The micd package provides add-on functionality for dealing with missing values to the existing pcalg R package, including methods for multiple imputations relying on the Missing At Random assumption. Also, micd allows for mixed measurement scales assuming conditional Gaussianity. The tpc package efficiently exploits temporal information in a way that results in a more informative output that is less prone to statistical errors.
Availability: The tpc and micd packages are freely available on the Comprehensive R Archive Network (CRAN). Their source code is also available on GitHub (https://github.com/bips-hb/micd; https://github.com/bips-hb/tpc).
动机彼得-克拉克(PC)算法是一种流行的因果发现方法,它以数据驱动的方式学习因果图。直到最近,R语言中现有的PC算法在缺失值、时间结构或混合测量尺度(分类/连续)方面都有很大的局限性,而这些都是队列数据的常见特征。本文介绍的新 R 软件包 micd 和 tpc 填补了这些空白。实现:micd 和 tpc 软件包均为 R 软件包:一般特点:micd 软件包为现有的 pcalg R 软件包提供了处理缺失值的附加功能,包括根据随机缺失假设进行多重估算的方法。此外,micd 还允许假设条件高斯性的混合测量尺度。tpc 软件包有效地利用了时间信息,使输出结果信息量更大,不易出现统计错误:tpc和micd软件包可在R档案综合网络(CRAN)上免费获取。它们的源代码也可在 GitHub 上获取(https://github.com/bips-hb/micd; https://github.com/bips-hb/tpc)。
{"title":"Software application profile: tpc and micd-R packages for causal discovery with incomplete cohort data.","authors":"Ryan M Andrews, Christine W Bang, Vanessa Didelez, Janine Witte, Ronja Foraita","doi":"10.1093/ije/dyae113","DOIUrl":"10.1093/ije/dyae113","url":null,"abstract":"<p><strong>Motivation: </strong>The Peter Clark (PC) algorithm is a popular causal discovery method to learn causal graphs in a data-driven way. Until recently, existing PC algorithm implementations in R had important limitations regarding missing values, temporal structure or mixed measurement scales (categorical/continuous), which are all common features of cohort data. The new R packages presented here, micd and tpc, fill these gaps.</p><p><strong>Implementation: </strong>micd and tpc packages are R packages.</p><p><strong>General features: </strong>The micd package provides add-on functionality for dealing with missing values to the existing pcalg R package, including methods for multiple imputations relying on the Missing At Random assumption. Also, micd allows for mixed measurement scales assuming conditional Gaussianity. The tpc package efficiently exploits temporal information in a way that results in a more informative output that is less prone to statistical errors.</p><p><strong>Availability: </strong>The tpc and micd packages are freely available on the Comprehensive R Archive Network (CRAN). Their source code is also available on GitHub (https://github.com/bips-hb/micd; https://github.com/bips-hb/tpc).</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sirwan K L Darweesh, Roel C H Vermeulen, Bastiaan R Bloem
{"title":"Paraquat and Parkinson's disease: has the burden of proof shifted?","authors":"Sirwan K L Darweesh, Roel C H Vermeulen, Bastiaan R Bloem","doi":"10.1093/ije/dyae126","DOIUrl":"https://doi.org/10.1093/ije/dyae126","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hmwe H Kyu, Jorge R Ledesma, Christopher J L Murray
{"title":"The Global Burden of Disease Study tuberculosis estimates from the Institute for Health Metrics and Evaluation.","authors":"Hmwe H Kyu, Jorge R Ledesma, Christopher J L Murray","doi":"10.1093/ije/dyae122","DOIUrl":"https://doi.org/10.1093/ije/dyae122","url":null,"abstract":"","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"53 5","pages":""},"PeriodicalIF":6.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11427672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142336408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}